Introduction
Latent herpes simplex virus type 1 (HSV-1) resides within neurons of sensory ganglia (Cook et al., 1974; McLennan & Darby, 1980) . During HSV-1 latency, viral transcripts have been detected by in situ hybridization in the central and peripheral nervous systems of mice (Deatly et al., 1987 (Deatly et al., , 1988 Mitchell et al., 1990a; Rock et al., 1987; Stevens et al., 1987; Stroop et al., 1984) Krause et al., 1988; Steiner et al., 1988; Stevens et al., 1988) . Within this region that is positive by in situ hybridization three latency-associated transcripts (LATs), 2"0 kb, 1.5 kb, and 1.45 kb, have been detected by Northern blot analysis (Rock et al., 1987; Stevens et al., 1987) , and their structure determined from cDNA clones and RNA-PCR products . In animal models, analyses of HSV-1 mutants with deletions that encompass the LAT promoter demonstrate that the LATs are not required for the establishment or maintenance of latent infection (Javier et al., 1988; Leib et al., 1989b; Steiner et al., 1989) , but that the LATs may augment the reactivation process in both explant and in vivo reactivation models J. G. Spivack and others (a) (b) (c) (1991) . (Hill et al., 1990; Javier et al., 1988; Leib et al., 1989b; Steiner et al., 1989; Trousdale et al., 1991) . Whether the action of the LATs is mediated by a protein product has not yet been determined.
The region positive during latent infection by in situ hybridization extends approximately 8 kb downstream from the 3' terminus of the 2.0 kb LAT (Fig. 1 c; Deatly et al., 1987; Mitchell et al., 1990a; Steiner et al., 1989) and overlaps with the genes encoding ICPO, an immediate early regulatory gene, and 734.5, a gene implicated in neurovirulence (Ackermann et al., 1986; Dolan et al., 1992; MacLean et al., 1991) . The revised DNA sequence predicts that the product of the 734.5 gene is a 263 amino acid protein in HSV-1 strain F ) and a 248 amino acid protein in strain 17 + (Dolan et al., 1992) . HSV-1 734.5 gene mutants are non-neurovirulent in mice (Bolovan et al., 1994; MacLean et al., 1991 ; Robertson et al., 1992; Valyi-Nagy et al., 1994) . Deletion of the corresponding region also abrogates neurovirulence in HSV-2 strains (Taha et al., 1989a, b) .
The following picture of the biological behaviour of the y34.5 gene is emerging: at some primary sites of infection (e.g. footpad, vagina) the replication of 734.5 mutants is less than that of wild-type virus, whereas in others (e.g. the eye) replication appears to be almost completely inhibited. The y34.5 gene mutants are replication defective in sensory ganglia and the CNS of mice (Bolovan et al., 1994; MacLean et al., 1991 ; McKie et al., 1994; Whitley et al., 1993) and guinea-pigs (Whitley et al., 1993) . Replication of 734.5 gene mutants in tissue culture cells is normal in several cell types, but is restricted in SK-N-SH neuroblastoma cells (Chou & Roizman, 1992) Latent infection with HSV-1 ?34.5 mutants 323 et al., 1994) and 3T6 cells . Therefore, both in vitro and in vivo the effect of the 734.5 gene on HSV-1 replication is cell type and tissue specific. It has been proposed that the ),34.5 gene promotes efficient replication in the central nervous system (CNS) by inhibiting HSV-l-induced shutoff of host protein synthesis and apoptosis (Chou & Roizman, 1992) . In this report two ?34.5 gene mutants were studied in the mouse eye model of latent infection to determine whether or not the ?34.5 gene affects the course of latent infection. An HSV-1 734.5 gene deletion mutant, 1716 ( Fig. 1 b) , is capable of limited replication in the footpads of mice, but is replication defective in the mouse peripheral nervous system (Robertson et al., 1992) . Although 1716 establishes latency in dorsal root ganglia (DRG), it is reactivation impaired (Robertson et al., 1992) . Since the 1716 deletion affects the primary LAT (Fig. lc) , HSV-1 strain 1771, which has a single stop codon 9 bp downstream of the ATG for the 734.50RF, was constructed. Strain 1771 does not synthesize the ?34.5 protein (McKie et al., 1994) , and should have a minimal effect on the LATs and other neighbouring transcripts. Comparison of 1716 and 1771 helped to determine whether changes in biological behaviour of these viruses were due to alterations in the 734.5 or LAT genes. The results suggest that the ?34.5 gene may affect several stages of latent infection: (i) the amount of virus available to establish latent infection, (ii) the establishment of latency, and/or (iii) the reactivation process. These data have implications for the development of HSV-1 734.5 mutants as vectors for gene therapy, cancer treatment and vaccination.
Methods
Cell culture, HSV-1 growth and titration. Subconfluent monolayers of BHK cells grown in Eagle's MEM (EMEM) supplemented with 10 % fetal calf serum at 37 °C with 5 % CO 2 were infected with HSV-1 strain 17 +, 1716 17 +, , 1771 17 +, , or rescuants, 1716R (MacLean et al., 1991 Dolan et al., 1992) or 1771R (McKie et al., 1994) . Virus was concentrated from the media and titrated on BHK cells, as previously described (Deatly et al., 1987; Spivack et al., 1987) .
Infection of mice and explant reactivation. Following corneal scarification, 4-to 6-week-old female BALB/cBYJ mice (Jackson Laboratories) were infected with between 1 x 106 and 3 x 107 p.f.u./eye of HSV-1 (Deatly et aL, 1987; Spivack et al., 1987; Stroop et al., 1984) . Some mice were infected via the footpad, as previously described (Robertson et al., 1992) . For measuring the amount of virus present during acute infection, mouse tissues were removed at the indicated times, homogenized, and virus titres determined by plaque assay. For latency studies, mice were sacrificed by cervical dislocation at a minimum of four weeks after infection. Trigeminal ganglia (TG) were dissected and processed for RNA or DNA isolation, or incubated with monolayers for explant reactivation of latent HSV-1.
RNA extraction, agarose gel electrophoresis, Northern blot transfer and hybridization. TG were homogenized in 4M-guanidinium thiocyanate, 0.5 % sodium-N-lauroylsarcosine, 100 mM-2-mercaptoethanol, 25 mM-sodium citrate and 0.1% Antifoam A (Sigma) pH 7.0 (Chirgwin et al., 1979) , and total RNA was isolated, as previously described . RNA was denatured with glyoxal, electrophoresed in 1.2 % agarose gels, and capillary blotted to Gene Screen Plus (Du Pont), as previously described . RNA markers were purchased from Bethesda Research Laboratories (BRL). Heat denatured 3ZP-labelled nick translated probes were added to Northern blots and hybridized overnight . The filters were washed in decreasing concentrations of SSC to 0.1 ×, with 1% SDS at 65 °C, for 2 x 30 min per wash, air dried, and autoradiographed with XAR-5 film (Kodak) at -70 °C with intensifying screens (Du Pont).
In situ hybridization. The in situ hybridization protocol with PLP-(2% paraformaldehyde, 0.1 M-lysine hydrochloride, 0.5M-sodium phosphate buffer pH 7.4, 0.1 M-sodium m-periodate) fixed and paraffinembedded TG was as previously described (Deatly et al., 1987; Stroop et al., 1984; Valyi-Nagy et al., 1991) . Tissues from several mice in each group were mounted in a single block. Tissues were hybridized with an 35S-labelled LAT-specific probe (BstEII-BstEII; Fig. 1 d) , washed, and exposed to emulsion (NTB2; Kodak).
DNA extraction for PCR. All procedures for preparing DNA templates and setting up reactions were performed in a separate laboratory dedicated for PCR. All of the scalpels, pipettes, dishes, etc. used were disposable, and all solutions for PCR were prepared in the PCR room to minimize the possibility of contamination. Mice were sacrificed by cervical dislocation. The desired tissues were removed using sterile disposable scalpels, placed in a small plastic Petri dish, and minced thoroughly until the tissue was ahnost liquified. The minced tissue was transferred into a microcentrifuge tube containing 0-5 ml of 160 mM-NaC1, 50 mM-EDTA, 5 mM-Tris HCI pH 8-0 plus SDS added to 0-5% (20% stock), and Pronase added to 1 mg/ml (5 mg/ml stock) just prior to use . The tissue homogenate was digested at 37 °C overnight, phenol/chloroform extracted, ethanol precipitated, resuspended in 100 gl 10mM-Tris ttC1, 1 mM-EDTA pH7.4, digested with RNase (100gg/ml) at 37°C for 1 h and Proteinase K (100 gg/ml) for 1 to 2 h. Then the samples were extracted with phenol, phenol/chloroform, and then chloroform, and ethanol precipitated. DNA amounts were measured by A260 measurements.
Agarose gel electrophoresis and Southern blot transfer of DNA (PCR products) were performed according to standard techniques (Maniatis et al., 1982) , as previously described (Mangano et al., 1992; Spivack et al., 1991) . After washing, the filters were air-dried, covered with plastic wrap and autoradiographed with XAR-5 film at -70 °C with intensifying screens.
PCR. PCR primers were chosen from the UL55 gene. The DNA sequence of the forward primer (55F) was 5'-CCTACGCGAACTGGAGGATAAG-3', and the sequence of the reverse primer (55R) was 5'-CATGCCGCTGGAGCTGATGGAG-Y. PCR was performed with 2.5 U of Taq polymerase (Promega), in 1 x Promega buffer with 0.25 to 0.5 gM primers, 100 gM-dNTPs, in a 25 gl volume overlaid with mineral oil, by 30 cycles of denaturation at 96 °C for 1 rain, annealing at 55 °C for 2 min and extension at 72 °C for 3min. PCR products (227bp) were resolved by agarose gel electrophoresis and visualized by ethidium bromide staining. A 123 bp ladder (BRL) was used for size markers.
Preparation of nick-translated probes. The BamHI B fragment of HSV-1 (F) cloned into pBR322 was obtained from B. Roizman (Post et al., 1980) . Subfragments of BamHI B were isolated from restriction digests by gel electrophoresis and electroelution onto DEAE-cellulose . DNA probes were nick-translated (Maniatis et al., 1982) and separated from unincorporated nucleotides by passage through 'mini-spin' Sephadex G-50 columns (Boehringer).
The specific activities of probes were typically 1 xl0 s 5 x 108 c.p.m./gg DNA.
to
Results
The ~34.5 neurovirulence gene is located in the long repeat region of HSV-1 (Fig. 1 b) , which overlaps with the mLAT (Mitchell et al., 1990a) , and an 8 kb to 9 kb RNA in infected tissue culture cells (Zwaagstra et al., 1990) . There is also evidence that several other transcripts map to the region of the 734.5 gene (Bohenzky et al., 1993; Yeh & Schaffer, 1993) . Thus, a 734.5 deletion mutant, such as 1716 (Fig. l b) , may actually affect several transcripts. To test the biological role of 734.5, 1716 and a stop codon mutant virus, 1771 (McKie et al., 1994) , were compared with 17 + and the rescuants 1771R and 1716R in the mouse eye model of latent infection.
Acute replication of 1716, 1771 and 17 + in mice following ocular inoculation
HSV-1 ~34.5 mutants replicate normally in several tissue culture cell lines MacLean et al., 1991; McKie et al., 1994 ). Yet in vivo, 1716, 1771 and other 734.5 mutants are avirulent following intracerebral (i.c.) inoculation of mice (Bolovan et al., 1994; MacLean et al., 1991; McKie et al., 1994) , owing to an inability to replicate in mouse CNS tissues MacLean et al., 1991) . However, strain 1716 does replicate to a limited extent at the site of inoculation of mice infected via the footpad, but not in the DRG (Robertson et al., 1992) . The replication of strain 1716 was studied in the eyes and TG of infected mice. In the experiments in Table 1 , BALB/cBYJ mice 4:~ 2"4 x 101 3"2 x 101 3'9 x 10 3 4"6 x 10 3 (1/7)
(1/7) (3/3) (3/3) 7 0 0 5"6 x 102 4"0 x 101 (0/3) (0/3) (2/3) (2/3) * The data are geometric means of the positive samples from two independent experiments, which include a total of 3-7 mice/time point, processed individually.
t In parentheses are the number of mice that are virus positive at each time point and the total number of mice tested.
At 4 days p.i. mice infected with 3 x 107 p.f.u, eye of HSV-1 strain 1771 were found to have no virus present in the eyes (0/5) or TG (0/5).
were infected with 3 x 107 p.f.u./eye of strain 1716. This was the maximum amount of virus that could be inoculated using 5 gl/eye of a high titre stock (6 x 109 p.f.u./ml). None of the 1716-infected mice died or developed any signs of illness. For comparison, mice were infected with 3 x 108 p.f.u./eye of strain 17 +. At this dose typically 10 to 60 % of infected mice die, and most of the mice exhibit signs of CNS disease, such as ruffled fur, hunched posture, and hind limb paralysis. Mice were not infected with 3 x 107 p.f.u, of strain 17 +, because all of the mice would be expected to succumb to infection. A small amount of 1716 was detected in the eyes only on the first day p.i. However, since the amount of virus present was over 100000-fold less than in the inoculum, this may have been residual virus. If there was any 1716 replication in the eye, the amount of virus present on day 1 could represent the amount produced in a single infected cell. Even though 10-fold more 1716 was used for infecting mice, no infectious virus was detected at any time in TG (the limit of detection was estimated at 10 to 20 p.f.u./tissue). Similar results were obtained in the eyes and TG of mice following infection with 106 p.f.u./eye of 1771 (Table 2) . However, a small amount of virus was detected in the eyes of a single mouse on days 2 and 4 p.i., and in the TG of a single animal on day 4 p.i. When the day 4 time point was repeated with mice infected with 3 x 107 p.f.u./eye of 1771, no infectious virus was observed (Table 2) . Therefore, the small amount of infectious 1771 present in the eyes and TG of single individuals after day 1 p.i. may be just an anomaly or statistical variation near the limit of detection. In contrast, 17 + and 1771R replicated in the eyes and TG of Ganglia incubated with monolayers of BHK cells were inspected daily for CPE and transferred to fresh BHK cells twice each week. Ganglia were considered reactivation negative after 1 month of explant incubation. infected mice, as previously reported (Steiner et al., 1989) .
Explant reactivation of 1716from the TG of mice
Results with several different HSV-1 mutants have demonstrated that viral replication in ganglia is not a requirement for the establishment of latent infection (Coen et al., 1989; Katz et al., 1990; Steiner et al., 1990) .
For example, HSV-1 strain in1814, an insertion mutant in the VP16 gene (UL48), does not replicate in the TG of infected mice, yet latent infection is established. The levels of the LATs are comparable to those found with 17 +, and the reactivation rate and frequency is normal Valyi-Nagy et al., 1991) . In marked contrast to in1814, 1716 did not establish reactivatable latent infection in the TG of mice (Fig. 2a) . No reactivation was detected from any of the ganglia form mice infected with 3 x 106 or 3 x 107 p.f.u./eye of strain 1716. Following inoculation with 106 p.f.u./eye, latent 1771 reactivated from 1/20 TG at 8 days post-explant (Fig. 2b) . Reactivation of latent 17 +, 1716R, or 1771R from mice infected with 1 x l0 G and 3 x 106 p.f.u./eye was observed in almost all of the ganglia between 4 and 9 days post-explant. Since, we were unable to reactivate 1716 from the TG of mice, the question arose whether or not 1716 DNA or the LATs were present in TG.
DNA levels in the TG and DRG of mice during the acute and latent stages of infection
Since 1716 did not reactivate from explanted TG, it was possible that the ability of 1716 and 1771 to establish latent infection was impaired, and the amount of latent 1716 DNA was greatly reduced compared to latent 17 + DNA. PCR combined with Southern blot analysis was used as the most sensitive assay for detecting low levels of latent HSV-1 DNA. Based upon reconstruction experiments, the detection limit in this assay with the UL55 primers was about 10 genome copies per ganglion (Valyi-Nagy et al., 1994) . HSV-1 PCR products were clearly detectable on ethidium bromide-stained gels with DNA templates from the eyes of 1716-and 17+-infected mice on days 2 and 4 p.i. (Table 3 ). The specificity of the PCR products was confirmed by Southern blot hybridization (data not shown). By day 2 p.i. 17 + DNA was present in TG, but 1716 was not; on day 4 p.i. the TG from 1/2 1716-infected mice was positive. In 1716 latently infected mice, 50 % (4/8) were positive for HSV-1 DNA, whereas all 17+-infected mice were positive (Table 3 ). This result indicated that (i) 1716 DNA was not cleared as rapidly from the eye as was infectious virus (compare days 2 and 4 p.i. in Table 1 with Table 3) , and (ii) that 1716 DNA reached the TG in about 50 % of the mice. 
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L A T expression during latency of 1716 and 1771 in mouse TG and in infected B H K cells
The inability o f 1716 and 1771 to reactivate from the T G of mice at 1 m o n t h p.i. might have been due in part to an effect of the 734.5 m u t a t i o n s on L A T gene function. To examine L A T expression, R N A was isolated at 1 m o n t h p.i. from the T G of mice inoculated with 1716 (3 x 106 and 3 x 107 p.f.u./eye), 1716R (3 x 106 p.f.u./eye), 1771 (10 ~ p.f.u./eye), 1771R (106 p.f.u./eye), and 17 + (106 and 3 x 10 ~ p.f.u./eye), N o r t h e r n blotted, and hybridized to a L A T probe. The 2.0 kb and 1.45 to 1.5 kb L A T s were readily detected in the samples from 17 + and 1716R latently infected mice ( (Fraser et al., 1992; Spivack et al., 1991) . Thus the lack of L A T expression in the T G of mice latently infected with 1716 was not the result of an inability to synthesize the 2.0 kb LAT. The 7 5 9 b p deletion in strain 1716 changes the structure o f the m L A T (Fig. 1 b and c) , which might lead to decreased stability of the m L A T , a n d / o r an alteration in post-transcriptional processing. Therefore L A T expression was studied in murine T G latently infected with 1771. A t 1 m o n t h p.i. with 1771 the L A T s were barely detectable in R N A isolated from the T G of mice (Fig.  4b, lane 2 (Fig. I d) . These data are presented quantitatively in Table 4 . 1771 was capable of synthesizing the 2.0 kb LAT in infected BHK cells (Fig. 4a) .
To determine whether any LAT expression occurred in the ganglia of mice at 1 month p.i. with 1716, in situ hybridization was performed with a LAT-specific BstEII-BstEII probe (see Fig. 1 d for location) . The LATs were barely detectable in a small number of neurons in the TG of mice latently infected with 3 × 107 p.f.u./eye of 1716 ( Fig. 5 and Table 4 ). The number of LAT-positive cells was reduced more than 100-fold, compared with mice infected with 3 x l0 G p.f.u./eye of 17 +. LAT-positive cells were not observed in the TG of mice infected with 3 x 106 p.f.u./eye of 1716 (Table 4 ). The number of LATpositive cells in ganglia latently infected with 1771 was approximately 10-fold less than in ganglia harbouring 17 + or 1771R (Table 4) .
Since 1716 was observed to reactivate at a low frequency from DRG explanted from mice latently infected via the footpad (Robertson et al., 1992) , but did not reactivate in the eye/TG model (Fig. 2a) , we examined LAT expression in the DRG of mice latently infected with 1716. In contrast to the TG, the LATs were detectable in the DRG of mice latently infected with 1716 (Fig. 5) , at levels that were only slightly reduced (three-to sixfold) compared to 17 + (Table 4 ). These data indicate that the difference in reactivation of latent 1716 between TG and DRG correlates with LAT expression levels in the sensory ganglia.
Discussion
Experiments with deletion mutants have demonstrated that the 734.5 gene is involved in the neurovirulence of HSV-1 (Bolovan et al., 1994; MacLean et al., 1991; McKie et al., 1994; Robertson et al., 1992; Valyi-Nagy et al., 1994; Whitley et al., 1993) and HSV-2 (Taha et al., 1989a, b) . However, this region of the genome is transcriptionally complex and deletions may also affect the expression and/or stability of the mLAT (Mitchell et al., 1990a) , and a family of recently described transcripts ( Fig. lc; Bohenzky et al., 1993; Yeh & Schaffer, 1993) . To address this concern about overlapping genes, 1771 and other 734.5 stop codon insertion mutants have been constructed. R4009 and 17termA contain a 20 bp oligonucleotide with stop codons in all reading frames 30 codons from the start of the 734.5 ORF Bolovan et al., 1994) . In this manuscript 1716 and 1771 were studied in a mouse eye model for replication, establishment of latent infection, explant reactivation, and LAT expression.
Although HSV-1 ?:34.5 gene mutants replicate at low levels at the site of inoculation following footpad (Robertson et al., 1992) or vaginal infection (Whitley et al., 1993) , they replicate poorly, or perhaps not at all, in the eye following corneal inoculation (Table 1 and 2) (Whitley et al., 1993) . The small amount of virus detected in the eye during the first few days post-infection may represent residual virus from the inoculum. Following inoculation of 734.5 mutants by any of these routes, infectious virus was rarely detected in the corresponding sensory ganglia (Table 1 and 2) (Robertson et al., 1992; Whitley et al., 1993) . In the CNS of mice 734.5 gene mutants are replication incompetent MacLean et al., 1991 ; Robertson et al., 1992; Taha et al., 1989a, b) . In contrast, HSV-1 734.5 gene mutants are replication competent in a variety of cell types from different species MacLean et al., 1991; McKie et al., 1994) , with the exceptions of a human neuroblastoma cell line, SK-N-SH (Chou & Roizman, 1992) , murine 10T1/2 cells, confluent primary mouse embryo cells (Bolovan et al., 1994) and 3T6 cells .
What is the function of the 734.5 gene in vivo during HSV-1 replication and also the establishment, maintenance and reactivation of latent infection? As a result of decreased replication of HSV-1 734.5 gene mutants at the site of inoculation, less virus may be available to establish latent infection, which may decrease latent viral DNA levels and LAT expression in TG. However, replication is not a strict requirement for the establishment of latency, since several replication incompetent strains establish latent infection, as defined by the presence of viral DNA (Katz et al., 1990; Leib et al., 1989a) . The amount of latent HSV-1 DNA is greatly reduced (Katz et al., 1990) , and these viruses are unable to reactivate because of their replication defects.
Following ocular inoculation, 1716 did not reactivate from any explanted TG (Fig. 2a) , and 1771 only reactivated from one ganglion (Fig. 2b) . 1716 reactivates, albeit at reduced levels, from DRG following footpad inoculation (Robertson et al., 1992) . The difference between TG and DRG in terms of reactivation and the number of LAT-positive cells (Fig. 5 and Table 4 ) emphasizes the tissue-specific nature of the requirement for 734.5 gene function. The simplest explanation for the different behaviour of 1716 in TG and DRG is that the establishment of reactivatable infection may be dependent upon replication at the site of inoculation. However, the impaired replication of 734.5 mutants is not sufficient to completely explain their reduced ability to reactivate from DRG and inability to reactivate from TG, because HSV-1 strain in1814, which replicates poorly in the eyes and TG of mice, reactivates normally from explanted TG . Owing to the high particle to p.f.u, ratio of in1814, inoculations of mice were performed with in1814, 17 + and in1814R both at equal infectious doses and at equal particle ratios. Following ocular infection of mice with 1.3 x 105 p.f.u.
(1.2 x 109 particles) of in1814, virus was reactivated from 19/20 TG. Even with 1.6 x 102 p.f.u./eye (1"5 x 106 particles) reactivation was observed in 4/14 TG . Since mice were infected with 1 x 106 p.f.u./eye of 1771 and up to 3 x 107 p.f.u./eye 1716, at least 10-to 100-fold more particles were used with 1716 and 1771 than at the low dose ofin1814. Thus, the observation that in1814 establishes reactivatable latent infection in TG whereas 1716 and 1771 do not, cannot be explained by the high particle/p.f.u, ratio of in1814.
LAT expression from 1716 and 1771 in tissue culture and in in vivo infection was studied to determine whether the reactivation defect was due to an effect on the LATs. In BHK cells both 1716 and 1771 expressed the 2"0 kb LAT at levels similar to those of 17 + (Fig. 3a and 4a) . The structure of the 2"0 kb LAT is not affected by the mutations in 1716 and 1771. Yet, during latent infection with 1716 the LATs were not detectable in TG by Northern blot analysis, even when mice were infected with 3 x 107 p.f.u./eye (Fig. 3b) . A few weakly positive neurons were detected by in situ hybridization (Fig 5) . The number of LAT-expressing cells in mice latently infected with 1716 was reduced more than 100-fold in TG, but only 3-to 6-fold in DRG (Table 4) . Thus, for strain 1716 there was a correlation between replication at the site of inoculation, the number of latently infected neurons in TG and DRG, and the frequency of reactivation. For 1716, the decreased number of latently infected cells that express the LATs might be partially due to altered mLAT. Since HSV-1 DNA was detected by PCR in only 50 % of the TG of mice latently infected with 1716, these data are consistent with fewer latently infected cells detected by in situ hybridization (Table 4 and Fig. 5) , suggesting that the effect of the 734.5 gene in establishment of latency may be partially related to replication at the site of inoculation.
Expression of the LATs was detectable by Northern blot analysis in the TG of mice latently infected with 1771, but was reduced about 10-fold compared with 17 + and 1771R (Fig. 4b, c) . By in situ hybridization, about 10-fold reduction in the number of latently infected neurons was detected in ganglia harbouring latent 1771 when compared to the number of LAT-positive cells in ganglia latently infected with 17 + or 1771R. The difference in LAT expression during latency between 1716 and 1771 may be that the 1716 deletion alters mLAT structure, while the 6 bp insertion in 1771 might not. The data suggest that the impaired ability of 1771 to establish latent infection is probably not due to an effect on the LAT gene (see below).
Is it possible that the 734.5 gene is also involved in reactivation, or that the almost complete inhibition of reactivation from TG is the result of mutation of the LAT gene? LAT promoter deletion mutants are replication competent in mice and reactivate with higher efficiency than 1716 or 1771 from explanted TG (Leib et al., 1989b; Steiner et al., 1989; Trousdale et al., 1991) , even though deletion of the LAT promoter abolishes LAT expression during latent infection (Mitchell et al., 1990b; Steiner et al., 1989; Trousdale et al., 1991) . Stable LAT expression is not required for efficient reactivation; there are HSV-1 deletion mutants that do not produce a stable LAT in either tissue culture or latent infections, yet reactivate normally Block et al., 1990) . Therefore, it is important to emphasize that an effect of the 1716 or 1771 mutations on mLAT expression is not sufficient to account for their reactivation defects. This suggests that the 734.5 gene may be directly involved in reactivation from latency, independent of the LAT gene.
However, since the 734.5 gene is by definition expressed late in infection and appears not to be a component of the virion (McKay et al., 1993) , it is difficult to envisage a role in the reactivation process. A novel regulatory pathway in neurons has recently been proposed in which limited e,/~ and 7 gene expression stimulates a second more vigorous round of viral replication (Kosz-Vnenchak et al., 1993) . A speculative possibility is that in neurons the 734.5 gene may be required for this second round of gene expression. Another possibility consistent with this hypothesis is the evidence that the 734.5 gene functions to inhibit shutoff of host protein synthesis in non-permissive SK-N-SH cells and to prevent apoptosis or normal cell death (Chou & Roizman, 1992) . During acute replication in the absence of a functional 734.5 gene, host protein synthesis would be inhibited, neurons would undergo cell death, and latent infections would be established in fewer cells than with wild-type virus. In addition, during reactivation in the absence of a functional 734.5 gene, neurons would also die, and reactivation would not progress through a complete HSV-1 replication cycle. Alternatively, the block in replication in the nervous system during acute infection and reactivation of latent infection may be due to the interaction of the 734.5 gene product with neuronal transcription factors or other viral proteins . Regardless of the mechanism, the current work indicates that not only does the 734.5 gene encode a neurovirulence factor, but that it is also involved in the pathogenesis of latent HSV-1 infections.
The current work has implications for the development of HSV-1 ~,34.5 gene mutants as vectors for several uses: (i) vaccination, (ii) gene therapy, and (iii) treatment of brain tumours. Because of safety concerns almost all HSV-1 vector strains currently under consideration are avirulent or replication incompetent. However, since replication-defective strains may not establish latency in sufficient numbers of neurons for effective gene therapy and are unable to selectively destroy tumour cells, there is continued interest in avirulent replication-competent HSV-1 vector strains. The lack of virulence combined with an impaired ability of 734.5 gene mutants to establish and reactivate from latency makes 734.5 gene mutant strains attractive as potential vaccine vectors. In contrast, the impairment of latency and low levels of LAT expression indicate that HSV-1 734.5 gene mutants may not be suitable for gene therapy vectors in the CNS. The ability to replicate in a variety of tissue culture cells, including human glioma cells (Markert et al., 1993) , but not in the CNS of rodents, suggests that HSV-1 ~34.5 gene mutants may be valuable in the treatment of brain tumours.
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